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ABSTRACT 24 
TLR9 deficient (TLR9-/-) mice are resistant to periodontitis, a disease 25 
characterized by a dysbiotic microbiota and deregulated immune response resulting in 26 
tooth loss and various systemic conditions. However, the mechanisms and biological 27 
pathways by which TLR9 instigates periodontal inflammation are yet to be identified. In 28 
a ligature-induced model of periodontitis, we demonstrate TLR9-/- mice exhibited 29 
significantly less alveolar bone loss compared to their wild-type (WT) counterparts.  30 
Consistent with the disease phenotype, gingival tissues showed significantly more 31 
inflammatory cell infiltrate in the WT ligated but not in the TLR9-/- ligated mice compared 32 
to their unligated controls. Peritoneal infection model using Porphymonas gingivalis, a 33 
keystone pathogen for periodontitis, revealed reduced neutrophils in TLR9-/- mice on 34 
day 1 post infection compared to WT mice. Transcriptomics analyses showed increased 35 
A20(TNFAIP3) expression, an inhibitor of NF-kappa B pathway and a negative regulator 36 
of TLR signaling, in ligated TLR9-/- gingival tissues compared to WT. Ex vivo, TLR9-/- 37 
bone marrow derived macrophages produced more A20 compared to WT cells following 38 
P. gingivalis challenge.  Clinically, A20 was modestly upregulated in human gingival 39 
tissues from chronic periodontitis patients further confirming the biological relevance of 40 
A20 in periodontal inflammation. We conclude that TLR9 modulates periodontal disease 41 
progression at both cellular and molecular levels and identify A20 as a novel 42 
downstream signaling molecule in the course of periodontal inflammation. 43 
Understanding the regulation of the TLR9 signaling pathway and the involvement of A20 44 
as a limiting factor of inflammation will uncover alternative therapeutic targets to treat 45 
periodontitis and other chronic inflammatory diseases.  46 
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INTRODUCTION 47 
 A key feature of the innate immune response to infectious microorganisms are 48 
pattern recognition receptors (PRRs) which respond to microbial components by 49 
activating pro-inflammatory molecules to limit microbial insult (1). However, deregulated 50 
immune responses and the failure of the immune system to resolve inflammation 51 
prolongs inflammatory response and lead to various chronic conditions including 52 
autoimmune disorders, persistent infectious and inflammatory disease, aging related 53 
metabolic conditions and cancer (2-5). Therefore, it is crucial to understand the 54 
molecular and biological pathways related to innate sensing, interaction of these 55 
pathways with each other and the resident microbiome to identify effective therapeutic 56 
targets to resolve inflammation and restore tissue homeostasis.  57 
Innate sensors such as Toll-like receptors (TLRs) play a critical role in immunity 58 
as a first line of defense. Although each TLR shows ligand specificity, downstream 59 
signaling pathways are redundant and likely communicate with each other. For 60 
example, except TLR3, all TLRs signal through the adaptor protein MyD88 which 61 
activates downstream cascades and transcription factors including mitogen-activated 62 
protein kinases (MAPKs), the nuclear factor κ light-chain enhancer of activated B cells 63 
(NF-κB), activator protein-1 (AP-1), and interferon regulator factors (IRF). Together, 64 
these signals culminate in a program of gene expression allowing de-novo 65 
cytokine/chemokine release while also coordinating the development of both the innate 66 
and adaptive immune response to eliminate the pathogen. Thorough understanding of 67 
the molecular mechanisms leading to the activation, regulation, and post-resolution 68 
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phase of TLR signaling is crucial in the development of therapeutics for inflammatory 69 
conditions.  70 
To avoid excessive inflammatory responses and to return tissues to 71 
homeostasis, host cells have developed negative regulation strategies of TLR signaling 72 
(6).  A number of regulatory programs have been described to inhibit inflammatory 73 
signaling cascades including deubiquitinating enzymes, sequestering adaptor proteins, 74 
activation of phosphatases, and expression of inhibitors (7). Emerging evidence has 75 
identified deubiquitinase (DUB), A20 which is encoded by the gene TNFAIP3 (TNF 76 
alpha induced protein 3), as a powerful negative regulator of TLR signaling and an 77 
inhibitor of NF-κB pathway.  A20 restricts inflammation triggered by TLRs by 78 
deubiquitinating TNF receptor associated factor (TRAF) 6 and preventing its interaction 79 
with the E2 ubiquitin-conjugating enzymes Ubc13 and UbcH5c. It also modifies Ubc13 80 
and UbcH5c by the addition of K48-linked ubiquitin chains, thus targeting these proteins 81 
for proteasomal degradation. Thus, A20 disrupts TLR signaling by preventing protein-82 
protein interactions necessary for the propagation of downstream signaling complexes, 83 
and down-regulates the production of pro-inflammatory cytokines. Furthermore, A20 84 
has been implicated as a disease susceptibility gene for many inflammatory and 85 
autoimmune disorders (8). Therefore, more studies are now exploring the potential of 86 
A20 as a therapeutic target.   87 
Periodontitis is one of the most prevalent oral diseases affecting almost half of 88 
the American population and associated with increased risk of systemic conditions 89 
including diabetes, cardiovascular disease, cancer, adverse pregnancy outcomes, 90 
gastrointestinal and pulmonary diseases, and rheumatoid arthritis (9-15).  While 91 
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periodontal diseases are initiated by periodontopathic bacteria and dysbiosis, the 92 
deregulated host inflammatory response to this dysbiotic microflora leads to destruction 93 
of the tooth supporting structures and eventual tooth loss (16).  In this regard, disease 94 
outcomes are often guided by the polymicrobial nature of the disease engaging multiple 95 
innate sensors, activating downstream inflammatory signaling cascades and the inability 96 
of the host to resolve inflammation which in turn provides nourishment to feed the 97 
dysbiosis.  A number of PRRs have been implicated in periodontal disease 98 
pathogenesis including plasma membrane-associated TLR2, TLR4, and complement 99 
receptors and more recently intracellular innate sensors such as TLR9 and NOD 100 
receptors (17-22).  The mechanisms by which TLR2 and complement receptors cause 101 
tissue damage in periodontitis are well documented with P. gingivalis, a keystone 102 
periodontal pathogen, instigating a crosstalk between these receptors in neutrophils to 103 
prevent the anti-microbial response while allowing the pro-inflammatory response to 104 
ensue (17). Specifically for TLR9, in vivo evidence revealed that TLR9 deficient (TLR9-/-) 105 
mice are resistant to periodontitis using an oral gavage model of periodontitis. This 106 
provided first proof of concept evidence that nucleic acid sensors are involved in 107 
periodontitis (18).  Furthermore, TLR9 has been shown to modulate TLR2 and TLR4 108 
triggered inflammation suggesting a cross-talk between these sensors possibly through 109 
downstream signaling pathways in the course of periodontal inflammation (18). Hence, 110 
understanding the mechanisms by which TLR9 contributes to periodontal inflammation 111 
can provide important insights on how to control aberrant periodontal inflammation and 112 
identify therapeutic targets and disease biomarkers critical both for local and systemic 113 
outcomes.    114 
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 The primary goal of the current study is to characterize the mechanisms by which 115 
TLR9 regulates periodontal inflammatory responses.  For this purpose, we induced 116 
periodontal disease in WT and TLR9-/- mice using a ligature-induced periodontitis model 117 
and measured global mRNA changes in the gingival tissues using PCR array analysis.  118 
Through this methodical study which includes in vivo, ex vivo and clinical studies, we 119 
report novel findings related to the interplay of neutrophils, macrophages, and A20, a 120 
host deubiquinating enzyme and negative regulator of TLR signaling as it pertains to 121 
periodontal disease.  To the best of our knowledge, this is the first study to determine 122 
the contribution of both A20 and TLR9 signaling in periodontitis.   123 
 124 
MATERIALS AND METHODS 125 
Human subjects and gingival tissue specimens.  The experimental protocol was 126 
approved by the Institutional Review Board of Virginia Commonwealth University and a 127 
written consent was obtained from each patient.  Twenty four healthy (H) subjects (6 128 
males and 18 females) and 49 chronic periodontitis (CP) patients (26 males and 23 129 
females) between the ages of 20 and 84 years old were included. The periodontitis 130 
subjects had pocket depths (PD) >4mm, clinical attachment loss (CAL) >2mm, bleeding 131 
on probing (BOP) and radiographic evidence of alveolar bone loss of at least two teeth 132 
(excluding 3rd molars) per quadrant. Healthy subjects had PD < 4mm, CAL < 2mm 133 
without bleeding on probing, no radiographic evidence of alveolar bone loss, and prior 134 
history of periodontitis (19). Individuals were excluded from the study for the following 135 
reasons; 1) pregnancy; 2) current or former smokers (quit smoking <15 years ago); 3) 136 
history of alcoholism, hepatitis, acquired immunodeficiency syndrome or human 137 
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immunodeficiency virus infection, diabetes, radiation therapy; 4) use of 138 
immunosuppressive medications, antibiotics, or non-steroidal anti-inflammatory drugs 139 
within the past 6 months; 5)  history of previous periodontal surgeries or localized drug 140 
delivery at the site to be sampled. Gingival biopsies were removed from each 141 
predetermined site and bisected longitudinally to generate samples for placement into 142 
two separate vials containing either a RNA stabilizing agent or 10% formalin.   143 
    144 
Mice.  All studies involving mice have been approved by the Institutional Animal Care 145 
and Use Committee (IACUC) at Virginia Commonwealth University.  BALB/c wild-type 146 
(WT) mice were purchased from Jackson Laboratory (Bar Harbor, ME).  TLR9-/- mice on 147 
the periodontitis-susceptible BALB/c background were obtained from Denis Klinmann 148 
(National Cancer Institute, Bethesda, MD) with the permission of Shizuo Akira (Osaka 149 
University).  All animals were housed in a sterile, specific-pathogen-free room in 150 
individual ventilated cages.   151 
 152 
Bacteria.  P. gingivalis (strain ATCC 33277) was grown in anaerobic conditions using 153 
brain heart infusion broth supplemented with 0.5% yeast extract, 5 ug/mL hemin, 0.5 154 
ug/mL vitamin K, and 0.1% cysteine as previously described (23). The bacteria was 155 
killed by heating at 80°C for 10 minutes following incubation on agar plates for 156 
verification (24).   157 
  158 
Ligature-induced periodontitis model.  Periodontal inflammation and bone loss were 159 
mechanically induced by ligature placement following previously published protocols 160 
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(22).  Briefly, 8-9 week old mice were administered kanamycin (1 g/liter) in the drinking 161 
water, followed by 5-7 days of antibiotic free water.  Mice were intraperitoneally 162 
anesthetized with a 200 uL mixture of ketamine (10 mg/mL) and xylazine.  A black 163 
braided silk 5-0 thread was placed at the left side of the maxilla interdentally between 164 
first and second maxillary molars.  The right side of the jaw was used as a control.   165 
Seven days after ligature placement, the mice were euthanized by isoflurane inhalation 166 
and cervical dislocation.     167 
 168 
P. gingivalis peritoneal cavity infection model.  WT and TLR9-/- mice were 169 
intraperitoneally infected with 1x108 CFU of live P. gingivalis (ATCC 33277) in 500 uL of 170 
sterile PBS.   On day 1, 2, and 3 post infection, mice were euthanized as described 171 
above.  To isolate peritoneal exudate cells (PECs), 5 mL of complete medium 172 
containing RPMI-1640 supplemented with 10% fetal calf serum (FCS), 10 mM HEPES, 173 
1 mM sodium pyruvate, 4,500 mg/L glucose, and 0.05 mM mercaptoethanol was 174 
injected into the peritoneal cavity of mice and the abdomen of the mice were massaged.  175 
PECs were recovered and red blood cells were osmotically lysed using ACK lysis buffer 176 
and resuspended in complete media.  For bone marrow cell isolation, both femurs and 177 
tibias were flushed with complete media.  Red blood cells were osmotically lysed as 178 
described above, and then washed and resuspended in complete media. 179 
 180 
Bone marrow-derived macrophage (BMDM) propagation and bacterial challenge.  181 
BMDM were generated according to standard protocols with minor adjustments (18).  182 
Briefly, bone marrow cells were isolated as described above and seeded in 100 mm 183 
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Petri dishes (non-tissue culture treated) at a concentration of 2x106 cells in 10 mL of 184 
bone marrow macrophage growth medium (BMM) (DMEM containing 4.5 g/liter glucose, 185 
100 mg/liter sodium pyruvate, 10% FCS, glutamine, 0.05 mM mercaptoethanol, and 186 
25% supernatant from L929 cells (ATCC CCL-1).  Cells were fed on day 3 by gently 187 
adding 10 mL of BMM.  On day 6, the macrophage monolayer was washed by 188 
aspirating the medium and gently adding PBS to remove any non-adherent or dead 189 
cells.  Adherent macrophages were harvested by adding PBS to the monolayer, 190 
incubating at 4oC for 10 minutes, and gently pipetting and scraping to remove cells.  191 
Macrophages were seeded in a 12 well plate at a concentration of 2x106 cells in 1 mL of 192 
BMM without L929 containing supernatant for 18 hours prior to stimulation. Heat-killed 193 
P. gingivalis was used to challenge BMDM at a multiplicity of infection (MO1) of 1:100.  194 
Unstimulated cells were used as negative controls.   195 
 196 
Surface staining and flow cytometry.  In this study, the following antibodies were 197 
used: anti-mouse Ly-6G (clone 1A8) fluorescein isothiocyanate (Ly-6G FITC), anti-198 
mouse TCR-β (clone H57-597) allophycocyanin (TCR-β APC), anti-mouse B220 (clone 199 
RA3-6B2) APC, anti-mouse/human CD11b (clone M1/70) Brillant Violet 711 (CD11b-200 
BV711), anti-mouse CD11c (clone N418) APC-Cy7, and anti-mouse F4/80 (clone BM8) 201 
phycoerythrin Cy7 (F4/80 PE-Cy7).  All antibodies were purchased from BioLegend.  202 
Surface staining was performed by incubating cells in a 1:100 dilution of antibody in 2% 203 
fluorescence-activated cell sorting (FACS) buffer (PBS supplemented with 2% FCS) for 204 
30 minutes on ice.  After washing three times in FACS buffer, cells were fixed in 2% 205 
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paraformaldehyde.  Samples were acquired on a BD LSRFortessa instrument and 206 
analyzed using FlowJo software.      207 
 208 
Determination of periodontal bone loss.  Alveolar bone loss around the maxillary 209 
molars was determined using micro-CT as described previously (25).  Briefly, for the 210 
ligature-induced periodontitis model, the entire head was harvested and fixed in 4% 211 
formaldehyde.  The Bruker SkyScan 1173 High Energy Micro Computated Technology 212 
(SkyScan NV, Kontich, Belgium) was used to acquire three-dimensional images in 213 
1,200 projections by 360 degree rotation.  A 250 millisecond exposure per projection, 80 214 
kilovolts, 80 microamps, an average image pixel of 16.87 micrometers, and a rotation 215 
step of 0.2 degrees was used to obtain an average scan time of 40 minutes.  Images 216 
were reconstructed using NRecon Software (Kontich, Belgium) with a Gaussian 217 
smoothing kernel of 2. Linear measurements for the distance from the cemento-enamel 218 
junction (CEJ) to the alveolar bone crest (ABC) was measured using Data Viewer 219 
(version 1.5.1, SkyScan NV) with a 1092 by 1092 pixel size in all three spatial 220 
dimensions and setting the sagittal plane parallel to the X-ray beam axis.  The CEJ-ABC 221 
distance for each mouse was subtracted from the mean CEJ-ABC distance of control 222 
mice.  The results were expressed in micrometers with negative values indicating bone 223 
loss relative to the results for control mice.  Three-dimensional analysis was determined 224 
using CTVox: Volume Rendering (version 3.0, SkyScan NV).         225 
 226 
Determination of bacterial counts.  The ligature associated bacteria counts were 227 
determined by previously published protocols (26). Briefly, ligatures were removed from 228 
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euthanized mice and washed gently in PBS to eliminate excess food.  The washed 229 
ligatures were then placed in 1 milliliter of PBS, vortexed gently for 2 minutes, serially 230 
diluted, and plated onto blood agar plates.  After anaerobic growth at 37oC for 7 days, 231 
bacteria were enumerated.  The results were normalized by dividing the total colony 232 
forming units (CFU) by the corresponding length in millimeters of the ligature.   233 
 234 
Immunohistochemistry  235 
Human tissues.  The A20 protein expression was determined by 236 
immunohistochemistry on 5 healthy and 6 chronic periodontitis patients as previously 237 
described by (19). Briefly, formalin-fixed gingival tissue sections collected from CP and 238 
H patients were deparaffinized, rehydrated, and submerged in 3% hydrogen peroxide.  239 
After washing with PBS, the slides were blocked with 5% horse serum for 1 hour at 240 
room temperature.  Slides were incubated with anti-A20 (TNFaip3) (Abcam) in a sealed 241 
humidifying tray overnight at 4oC.  The following day, tissues were incubated with biotin-242 
conjugated anti-rabbit IgG for 1 hour at room temperature.  After washing in PBS, slides 243 
were incubated with avidin-peroxidase reagent followed by staining with 244 
diaminobenzidine solution and counterstaining with hematoxylin (ABC kit Vectastain).  245 
Slides were dehydrated and permanently mounted.  Negative controls which omitted the 246 
primary antibody were run in parallel.  The staining intensity and distribution was 247 
determined by light microscopy.  To quantify the percent of diaminobenzidine positive 248 
areas within a region, the cellSens software was used and six fields of view were 249 
analyzed for each patient at a magnification of 200X.   250 
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Mouse tissues.  Explanted gingival tissues from WT (n=4) and TLR9-/- (n=4) mice were 251 
fixed in 4% formaldehyde, sectioned, and stained with hematoxylin and eosin (H&E) 252 
using standard protocols.  Histology images were acquired using QColor 5 Imaging 253 
System from Olympus Microscopy with a 10X magnification objective lens.  The 254 
cellSens software was used to quantify the percent of nucleated cells (hematoxylin-255 
positive) cells in the gingival tissue.  Six regions/fields of view were analyzed for each 256 
mouse.   257 
 258 
Western Blotting.  Murine BMDM samples were lysed in 100 uL of ice-cold NP-40 lysis 259 
buffer (25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 1 mM EDTA, pH 8) 260 
supplemented with 1 mM phenylmethylsulfonyl fluoride, 1 mM Na3VO4, 1 mM 261 
dithiothreitol, and 1X protease inhibitor cocktail (Sigma-Aldrich) by repeated pipetting.  262 
For murine and human gingival tissues, samples were minced and homogenized in lysis 263 
buffer described above.  All samples were sonicated twice at 50% pulse for 30 seconds 264 
each time using an ultrasonic sonicator (BioLogics, Inc., Cary, NC).  The protein 265 
concentration was determined using the bicinchoninic acid (BCA) protein assay kit 266 
(Thermo Scientific).  Cell lysates were subjected to electrophoresis on 4-15% Mini-267 
Protean TGX gels (Bio-Rad) and transferred to nitrocellulose membranes.  Membranes 268 
were probed with A20/TNFAIP3 (D13H3) (Cell Signaling Technologies) according to the 269 
manufacturer’s protocol.  Bands were visualized using SuperSignal West Pico 270 
chemiluminescent substrate (Thermo Scientific) followed by exposure to X-ray film.  271 
Densitometric analyses were performed using the G:BOX Chem XX6 system and 272 
GeneTools image analysis software (Syngene).  To determine the fold-increase in A20 273 
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expression for BMDM experiments, all samples were first normalized to the levels of 274 
actin.  The fold increase was calculated by dividing the normalized A20 value for the 275 
stimulated sample by the corresponding unstimulated negative control.       276 
 277 
RNA isolation, PCR Array, and Quantitative real-time PCR.  Total RNA was 278 
extracted from mouse or human gingival tissues and BMDM using the RNeasy kit 279 
(Qiagen) and gDNA eliminator spin columns.  For array analysis, 500 ng of RNA was 280 
used to synthesize cDNA using the RT2 First Strand Kit (Qiagen) according to 281 
manufacturer’s protocol.  The expression of genes in the TLR signaling pathway was 282 
determined by real-time PCR using the RT2 Profiler PCR Array (PAMM-018Z) (Qiagen) 283 
with the Applied Biosystems 7500 X Real-Time PCR System.  Analysis of PCR array 284 
data set was performed on the manufacturer’s website.    285 
For all other quantitative real time PCR analysis, cDNA was synthesized from 1 286 
μg of RNA using a high capacity cDNA reverse transcription kit (Applied Biosystems) 287 
according to the manufacturer’s protocol.  The quantitative real-time PCR with cDNA 288 
was performed with the Applied Biosystems 7500 X Real-Time PCR System using 289 
SYBR green master mix (SaBiosciences) and the following specific primer sets: GAPDH 290 
(mouse), forward, 5' AGG TCG GTG TGA ACG GAT TTG 3', and reverse, 5' GGG GTC 291 
GTT GAT GGC AAC A 3'; TNFaip3/A20 (mouse), forward, 5’ GAA CAG CGA TCA 292 
GGC CAG G 3’, and reverse, 5’ GGA CAG TTG GGT GTC TCA CAT T 3’, GAPDH 293 
(human), forward, 5’ CAA TGA CCC CTT CAT TGA CC 3’, and reverse, 5’ TTG ATT 294 
TTG GAG GGA TCT CG 3’; TNFaip3/A20 (human), forward, 5’ TTG TCC TCA GTT 295 
TCG GGA GAT 3’, and reverse, 5’ ACT TCT CGA CAC CAG TTG AGT T 3’.  The 296 
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GAPDH gene was used as an internal control.  The relative amount of each mRNA was 297 
calculated using the cycle threshold (2-ΔΔCT) method, where ΔCT=(CTmRNA-CTGAPDH).   298 
 299 
Statistical Analysis.  Data were analyzed by one-way analysis of variance (ANOVA) 300 
and the Tukey multiple-comparison test or unpaired t test with Mann-Whitney correction 301 
using the InStat program (GraphPad Software, San Diego, CA).  Spearman test was 302 
performed to detect the correlation between the bacterial load and bone loss. In the 303 
analyses of clinical samples, demographic variables including race, gender and age 304 
between the healthy and disease groups were compared using two-sample T-test and 305 
Fisher’s Exact Test. Multivariate regression analysis was used to determine the impact 306 
of the disease on the A20 levels.  A p value of <0.05 was considered significant.   307 
 308 
RESULTS 309 
TLR9 promotes alveolar bone loss in a murine ligature-induced model of 310 
periodontitis.  Our previous study identified that in vivo TLR9 signaling facilitates 311 
inflammatory and osteoclastogenic cytokine activation and subsequent alveolar bone 312 
loss in a chronic periodontitis model using Porphymonas gingivalis oral gavage (18).  To 313 
better understand the mechanism by which TLR9 contributes to periodontitis 314 
pathogenesis, we utilized the mechanically induced ligature model for periodontal 315 
disease in which silk sutures were placed in between all molar teeth.  This model 316 
represents a more aggressive form of the disease which is characterized by rapidly 317 
progressing bone loss (17, 27).  Micro-CT imaging of alveolar bone levels revealed 318 
substantial visible bone destruction in WT ligature mice, while bone loss was not evident 319 
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in TLR9-/- mice (Figure 1A).  The change in the maxillary bone loss for ligated mice was 320 
determined by subtracting the mean CEJ-ABC distance among unligated controls and 321 
subtracting it from the CEJ-ABC distance measured for each ligature mouse.  Our data 322 
revealed significant bone loss in the WT ligature mice compared to WT unligated control 323 
sites (Figure 1B).  Although there was slight, insignificant bone loss in the TLR9-/- 324 
ligature mice compared to TLR9-/- controls, WT ligature mice exhibited significantly more 325 
bone loss than TLR9-/- ligature mice (Figure 1B). TLR9 deficiency did not significantly 326 
affect the number of ligature associated periodontal bacteria burden when compared to 327 
WT mice (Figure 1C).  As shown in Figure 1C, the bacterial burden reached 8.5 x 104 328 
CFU per millimeter of ligature in WT mice at the time of euthanasia (day 7).  When 329 
bacteria in TLR9-/- mice were examined, there was 7.1 x 104 CFU per millimeter of 330 
ligature. Spearman test results revealed no correlation between the amount of bone 331 
loss and the bacterial load in each group (data not shown). Taken together, these 332 
results demonstrate that TLR9 signaling but not differences in the bacterial load is 333 
associated with the induction of bone loss in the murine ligature-induced periodontitis 334 
model. It is yet to be determined however whether there were any differences in the 335 
composition of the bacteria among different genotypes.  336 
 TLR9 deficiency reduces inflammatory cell infiltrate in both the ligature 337 
induced periodontitis and P. gingivalis intraperitoneal infection models.  During 338 
periodontal disease, deregulated immune and inflammatory responses in reaction to the 339 
dysbiotic microflora are responsible for the events leading to bone resorption.  Our 340 
previous work demonstrated TLR9-/- mice when compared to their WT controls exhibited 341 
decreased expression of pro-inflammatory cytokines, IL-6 and TNF, and the 342 
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osteoclastogenic molecule, RANKL following the oral gavage infection model (18).  We 343 
therefore hypothesized that TLR9 promotes inflammation by increased immune cell 344 
infiltrate at the local site of infection.  To investigate this, dissected tissues from each 345 
group of WT and TLR9-/- mice were processed for H&E staining to examine immune cell 346 
infiltrate during the ligature model.  In line with the bone loss data, WT mice exhibited 347 
extensive inflammatory cell infiltrate as assessed by hematoxylin-positive nucleated 348 
cells in the connective tissue of the gingiva following ligation (Figure 1D and E).  When 349 
the infiltrate in the ligated TLR9-/- mice were examined, the response was drastically 350 
reduced, matching that of the control animals (Figure 1D and E).  Because the 351 
inflammatory cell infiltrate was less in the gingival tissues of TLR9-/- ligated mice, we 352 
next determined whether lack of TLR9 affects cellular innate immune response in vivo 353 
following P. gingivalis peritoneal infection model.  On day 1 post infection, the 354 
percentage of neutrophils (CD11b+ Ly-6G+) increased 331-fold in WT mice compared 355 
to non-infected controls, and this was significantly reduced by half (118-fold) in TLR9-/- 356 
mice (Figure 2A and B).  By day 2 and 3 post-infection, similar levels of neutrophils 357 
were detected for both genotypes.  Macrophages are critical to the periodontal lesions 358 
taking part both in innate and adaptive immunity.  Therefore, we also determined 359 
whether TLR9-/- affected the distribution of macrophages in the peritoneal infection 360 
model.  When we assessed the percentage of cells on day 1, 2, and 3 post-infection, we 361 
found that there was no significant difference in the distribution of macrophages 362 
(CD11b+ F4/80+) between TLR9-/- mice and their WT counterparts (Figure 2A and C).  363 
Taken together, these results demonstrate that abolishing TLR9 signaling reduces 364 
inflammatory cell infiltrate in both the ligature and peritoneal infection model. Although 365 
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neutrophils are the first line of defense, aberrant neutrophil activity is associated with 366 
the exacerbated inflammation and catabolic events leading to periodontal tissue 367 
destruction. It is therefore likely that more controlled neutrophil recruitment to the sites 368 
in TLR9-/- mice during the early phases of the disease may be critical in regulating 369 
inflammatory response and promoting resolution.  370 
 Increased A20 mRNA expression in the gingival tissues of TLR9-/- mice 371 
following ligature placement.  The TLR signaling pathway was examined in order to 372 
identify any differences in the expression patterns of signaling molecules and 373 
inflammatory mediators which could help explain the mechanism by which TLR9 374 
contributes to periodontal disease pathogenesis.  A PCR array composed of 84 genes 375 
was conducted in control and ligated gingival tissues from WT and TLR9-/- mice (Figure 376 
3A).  When a 1.5 fold difference was considered, we identified a number of genes which 377 
were differentially expressed in the gingival tissues of WT versus TLR9-/- mice (Figure 378 
3B). These differences imply that there might be key downstream molecules regulating 379 
TLR9-mediated inflammation in the course of periodontitis limiting the disease in TLR9-/- 380 
mice. In fact, A20, a negative regulator of TLR signaling and an inhibitor of NF-κB 381 
pathway, was one of the genes that was significantly upregulated in TLR9-/- ligated 382 
tissues but not in WT ligated tissues. Consistent with the results of the arrays, increased 383 
A20 expression in the gingival tissues from TLR9-/- ligated mice were further verified 384 
using independent primer sets and GAPDH as a control (Figure 3C).  A20 is a newly 385 
emerging endogenous regulator of inflammation and associated with several receptors, 386 
downstream molecules and cellular processes that are involved in the course of 387 
periodontal inflammation (8, 28). Previous studies reported that the inflammatory 388 
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cytokine production was decreased in TLR9-/- BMDM compared to WT BMDM following 389 
P. gingivalis challenge (18). Current findings combined with the findings of the previous 390 
reports prompted us to hypothesize that A20 might be a key downstream molecule 391 
limiting periodontal inflammation. Therefore, our subsequent studies focused on A20 as 392 
a potential downstream mediator which could explain why TLR9 deficiency ameliorates 393 
periodontal disease.  394 
 Lack of TLR9 signaling increases A20 protein expression in BMDM 395 
challenged with P. gingivalis.  We sought to examine whether the alterations in A20 396 
expression found in the PCR array could explain the functional differences in cytokine 397 
responses between TLR9-/-  and WT BMDM (18).  To address this question, WT and 398 
TLR9-/- BMDM were stimulated for 2, 4, or 6 hours with P. gingivalis and A20 expression 399 
was examined.  Figure 4A shows that following P. gingivalis challenge, A20 mRNA 400 
expression was slightly elevated in TLR9-/- BMDM, but this difference was not 401 
statistically significant compared to WT BMDM.  In Figure 4B and C, we compared the 402 
A20 protein levels between WT and TLR9-/- BMDM.  In WT BMDM, A20 increased 5.9-403 
fold over unstimulated cells by 2 hours and reached a peak of 7.5-fold by 4 hours.  404 
When A20 protein in TLR9-/- BMDM was examined, levels increased 11.3-fold 405 
compared to unstimulated cells by 2 hours.  Analyses of the 4 and 6 hour time points in 406 
TLR9-/- BMDM revealed a 22-fold and 26-fold increase in A20 levels compared to 407 
unstimulated controls and the change was significantly different between WT and  408 
TLR9-/-  cells. Taken together, our findings imply that abolishing TLR9 signaling results 409 
in increased cellular A20 levels and possibly increased A20 activity subsequently 410 
regulating cytokine production in response to bacterial challenge.   411 
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Increased A20 expression in periodontitis patients compared to healthy 412 
controls.  To our knowledge, A20 expression has not been investigated in a well-413 
defined set of periodontitis patients yet. To provide additional support that A20 is 414 
clinically relevant and is associated with periodontal disease, we analyzed the A20 415 
expression in gingival biopsies from healthy individuals and periodontitis patients.  Table 416 
1 summarizes the demographic characteristics of the study population including age, 417 
gender, and race as well as the clinical parameters at the sampled teeth. Comparison of 418 
demographic variables between the healthy and disease groups shows statistically 419 
significant differences in gender (p-value =0.03) and age distribution (p-value <0.01). 420 
After controlling for these differences using multivariate regression analysis, there was a 421 
significant increase in A20 mRNA expression in the gingival tissue biopsies of 422 
periodontitis subjects compared to the tissues obtained from healthy controls (p<0.01) 423 
(Figure 5A). In contrast, there was a modest yet statistically insignificant increase in A20 424 
protein levels in diseased versus control group (Figure 5B and C). We also wanted to 425 
determine the localization of A20 within the oral mucosa in diseased versus healthy 426 
tissues. Further analyses using IHC revealed both healthy and diseased patients exhibit 427 
low constitutive A20 expression in the gingival epithelium (Figure 5D). However, strong 428 
A20 staining was observed in the underlying gingival connective tissue of chronic 429 
periodontitis patients compared to healthy controls (Figure 5D).  Quantification of 3, 3’-430 
diaminobenzidine staining in the epithelium and connective tissues revealed a slight 431 
increase in A20 expression in the diseased patients compared to healthy controls 432 
(Figure 5E).  Demonstration of A20 expression clinically in chronic periodontitis tissues 433 
further confirms the clinical relevance of this molecule in periodontal inflammation.     434 
 o
n
 D
ecem
ber 11, 2017 by NO
VA SO
UTHEASTERN UNIV
http://iai.asm
.org/
D
ow
nloaded from
 
20 
 
DISCUSSION 435 
 In this study, we examined the role and the mechanism by which TLR9 436 
modulates periodontal disease using in vivo, ex vivo and clinical studies.  Here, we 437 
report five novel observations. First, TLR9 signaling promotes alveolar bone loss in an 438 
experimental murine ligature induced model of periodontitis.  Second, A20 expression 439 
was significantly increased in TLR9-/- ligated mice compared to WT ligated mice. Third, 440 
loss of TLR9 diminished the number of infiltrating neutrophils at the early phases of 441 
inflammation following intraperitoneal P. gingivalis infection.  Fourth, ex vivo, TLR9-/- 442 
BMDMs challenged with P. gingivalis exhibited increased A20 protein expression 443 
compared to WT BMDMs.   Fifth, human gingival biopsies from chronic periodontitis 444 
patients exhibited a modest increase in A20 mRNA and protein expression compared to 445 
healthy controls.  Together, we believe these results are novel and highlight the 446 
interplay of multiple cell types and signaling pathways in the progression of periodontal 447 
inflammation and identify a novel downstream molecule that may regulate local 448 
inflammatory responses. 449 
 What are the implications of these findings?  Many periodontitis patients develop 450 
reoccurring disease because conventional therapies are not effective at controlling host 451 
inflammation.  Therefore, current research efforts focus on the discovery of new 452 
therapeutic avenues.  In this regard, prior studies from our laboratory and others have 453 
demonstrated that TLR9 signaling contributes to periodontal inflammation and alveolar 454 
bone loss (18).  We extend these studies and our results have implications in 455 
understanding the immunopathology and the cellular mechanisms by which TLR9 456 
signaling instigates periodontal inflammation.   457 
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The first association concerns with the role of TLR9 and neutrophils. Neutrophils 458 
act as double-edge swords during periodontal inflammation and should be tightly 459 
regulated by the host to initiate the immediate immune response to combat infection 460 
while limiting prolong cellular recruitment and activity to prevent tissue injury.  It is well-461 
documented that neutrophil migration and extravasation in periodontitis are governed by 462 
decreased Del-1 and increased IL-17 expression levels (29-31).  Our flow cytometry 463 
observations of decreased percentages of neutrophils (CD11b+ Ly-6G+) in TLR9-/- mice 464 
following the lavage infection model are similar to that of aged mice administered Del-1 465 
in the gingival tissues. Hence, it is likely that even a slight shift in neutrophil 466 
recruitment/activity in TLR9 KO animals could be responsible for regulating and limiting 467 
aberrant tissue responses and eventually periodontal inflammation.  468 
Secondly, the role of TLR9 in periodontal inflammation was not restricted to 469 
regulating the generation of innate immune cells. In contrast to the neutrophil data, no 470 
difference in the percentages of macrophages (CD11b+ F4/80+) was detected with 471 
intraperitoneal infections between WT and TLR9-/- mice. Still, even though the numbers 472 
were not affected, functional changes in the cellular activity would account for the 473 
overall inflammatory response. In fact, we reported previously that TLR9-/- BMDMs 474 
exhibit decreased TNF and IL-6 production when stimulated with P. gingivalis compared 475 
to their WT counterparts (18).  We extend these previous studies and determined the 476 
increased expression of A20 protein in the TLR9-/-macrophages compared to WT cells 477 
which could possibly explain a mechanism by which TLR9-/- limits inflammation during 478 
the various experimental periodontitis models. Yet, future investigations are warranted 479 
to fully characterize the observed associations. 480 
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A20 is promiscuous in that not only does it target the redundant, downstream 481 
TLR signaling pathways, but it also targets many other inflammatory pathways which 482 
are relevant to periodontal inflammation including TLR2, TLR4, Nucleotide-binding 483 
Oligomerization Domain containing (NOD) 1/2 receptors, T cell receptor (TCR), TNF, IL-484 
1, IL-17 and the nucleosome complex. A20 inhibits inflammation through interfering with 485 
NF-κB, MAPK and interferon regulatory factor pathways and regulates cellular functions 486 
including apoptosis, necroptosis and autophagy in several models of inflammatory 487 
diseases and cell types (32). Further, increased A20 expression or activity has also 488 
been associated with dampening numerous disease outcomes (33) (34). Thus, there is 489 
a great interest in manipulating A20 for therapeutic benefit (35).  In regards to the TLR 490 
pathways, prior studies have identified cross-talk between TLR9, TLR2, and TLR4 in 491 
both periodontitis and other disease models (18, 36).  For periodontal inflammation, we 492 
demonstrated TLR9-/- BMDM challenged with TLR2 and TLR4 agonists exhibited 493 
decreased cytokine production when compared to WT cells (18).  Our observation that 494 
A20 is up-regulated in TLR9-/- BMDM following P. gingivalis stimulation, which activates 495 
multiple innate sensors strongly argues that A20 might be a key downstream molecule 496 
that limits inflammation triggered by activation of other receptors as well.  Furthermore, 497 
the additional inflammatory pathways described above have also been associated with 498 
periodontal inflammation.  Therefore future studies are warranted to delineate regulatory 499 
mechanisms for A20 and how it interacts with multiple signaling pathways possibly 500 
affecting immune cell plasticity in the course of periodontitis. 501 
In regards to the human studies, we detected a significant increase in A20 mRNA 502 
expression and a modest but insignificant increase in protein levels in chronic 503 
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periodontitis patients compared to healthy controls. Physiologically, A20 is constitutively 504 
expressed in low levels and can be further induced by microbial components (e.g. LPS) 505 
and cytokines (e.g. IL-1, TNF, IL-17) in many cell types which are relevant to 506 
periodontitis. Because the study participants exhibited severe forms of the disease 507 
compared to healthy tissues, up-regulation of A20 was expected in the diseased tissues 508 
as part of the inflammatory cascade. However, why does this increase not resolve 509 
inflammation resulting in changes in the clinical signs of the disease? TLR9 is one of the 510 
most up-regulated PRRs in chronic periodontitis (19). It is possible that although still 511 
being a functional protein in the course of periodontitis, A20 expression did not reach 512 
sufficient levels to facilitate the resolution of inflammation. Thus, the questions remain to 513 
be answered are how A20 level and activity are regulated and whether the manipulation 514 
of A20 can prevent further periodontal tissue destruction similar to its effects in other 515 
inflammatory diseases (33-35). 516 
Several studies have determined A20 expression is regulated by miRNAs (37-517 
39).  In diffuse large B cell lymphoma, overexpression of miR-125a and miR125b has 518 
been shown to suppress A20 expression contributing to NF-κB-mediated inflammation 519 
(37).  In contrast, studies have also determined A20 is protected from HuR degradation 520 
by miR-29 (40).  Another study reported that downregulation of let-7f, another miRNA, 521 
during M. tuberculosis infection enhances A20 expression, thereby attenuating 522 
inflammatory signaling and facilitating bacterial survival (34). Thus, miRNAs can impact 523 
A20 protein expression. Our in vitro findings further support this notion. Even though 524 
A20 protein levels were increased in P.gingivalis challenged BMDMs in TLR9-/- mice 525 
compared to their WT counterparts, A20 mRNA levels were similar between WT and 526 
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TLR9-/- mice suggesting that the regulation of A20 differs between these genotypes 527 
probably either at the post-transcriptional or translational level. However, it is also 528 
possible that A20 expression was increased in the earlier times (< 1 hours) during the 529 
infection. In addition, A20 protein has a relatively long half-life and it has been 530 
suggested that steady-state levels of A20 may regulate the magnitude of inflammation 531 
which can provide further explanation for the differences between mRNA and protein 532 
expression ex vivo (41).  Similarly, although there was a significant increase in A20 533 
gene expression in diseased tissues, the protein levels were not significantly different 534 
between groups. Considering the recent studies reporting differential expression of the 535 
miRNA-29 and miRNA-125 families between periodontitis patients and healthy controls, 536 
it will be important to determine the effect of differential miRNA expression in 537 
inflammation in these individuals and if A20 levels and activity can be regulated with 538 
specific miRNA in the course of periodontitis (42).  It will also be crucial to determine the 539 
interaction of A20 with other components of the host immune system and resident 540 
microbiome and how these interactions modulate the activity of the protein.  541 
Consistent with western blotting analyses, IHC results also revealed modest yet 542 
insignificant increase in A20 protein levels in periodontitis tissues compared to healthy 543 
tissues. While comparable levels of A20 expression was observed in the gingival 544 
epithelium of both healthy and diseased subjects, A20 staining was stronger in the 545 
underlying gingival connective tissue in chronic periodontitis patients compared to 546 
healthy controls. These observations imply that in the course of periodontal 547 
inflammation, A20 expression varies among different tissues. A20 is indispensable for 548 
survival as complete knockout of A20 in a mouse model leads to multi-organ 549 
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inflammation and early death within 3 weeks after birth (9). This also corroborates that 550 
A20 is important for the resolution of inflammation. Therefore, it will be important to 551 
assess whether the variations in A20 expression in different cells affect periodontal 552 
disease pathogenesis.    553 
The challenge to studying chronic inflammatory conditions is characterizing the 554 
complex network of biological and molecular pathways, how they are regulated, their 555 
ability to communicate with one another and facilitate the pro-inflammatory, anti-556 
inflammatory, and resolution phases of the disease.  TLR9 is unique as it can engage 557 
both microbial nucleic acids and danger associated molecular patterns (DAMPs) (20) 558 
and communicate with other TLRs. Current study provides experimental evidence that 559 
TLR9 modulates periodontal inflammation both at the cellular and molecular level using 560 
ligature, intraperitoneal, and ex vivo models (Figure 6). We also reveal A20, an 561 
endogenous regulator of inflammation, as a new molecule that may play role in 562 
periodontal inflammation. In addition, we report A20 expression in human clinical 563 
gingival biopsies corroborating its expression in the local tissues within the oral cavity. 564 
New therapeutic designs are critical to fine-tune the course of inflammation away from 565 
damaging, chronic inflammation and towards acute inflammation which is resolved to 566 
restore tissue homeostasis. A20 is a common downstream molecule for all TLR 567 
signaling pathways and additional pathways including other PRRs, cytokine receptors, 568 
lymphocyte receptors and apoptosis/necroptosis pathways. Therefore, it will be 569 
important to determine the exact role of A20 in periodontal disease pathogenesis and 570 
the mechanisms by which innate sensors communicate with each other and A20 to 571 
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develop alternative strategies to treat polymicrobial and inflammatory diseases like 572 
chronic periodontitis and autoimmune disorders. 573 
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Figure Legends 718 
Figure 1.  TLR9 deficiency prevents ligature-induced periodontal bone loss in vivo.  On 719 
day 7 following ligature placement, WT and TLR9-/- mice were sacrificed and entire 720 
heads were processed for micro-CT imaging.  (A) Representative micro-CT images of 721 
maxillae from each group of animals.  (B) Amount of bone change in WT and TLR9-/- 722 
mice.  Negative values represent bone loss in ligated mice relative to the results for the 723 
control (unligated) mice. Ten to eighteen mice were analyzed.  (C) CFU enumeration of 724 
periodontal microflora recovered from the ligatures of WT and TLR9-/- mice. The 725 
numbers were determined by bacteria extraction from the ligatures and serial dilutions 726 
of bacterial suspensions were plated onto blood agar plates for anaerobic growth. The 727 
averages and standard deviations are shown. Six to seven mice were included. (D) 728 
Gingival tissues were harvested, sectioned, and processed for H&E staining.  Data are 729 
(D) representative images and (E) quantification of from 4 WT and 4 TLR9-/- mice 730 
showing inflammatory cells from ligated and control sections.  Four mice were analyzed 731 
in triplicate to sextuplicate in a minimum of 2 independent experiments with averages 732 
and standard deviations shown. *, P<0.05; **** P<0.0001. 733 
 734 
Figure 2.  Decreased inflammatory cell infiltrate in the peritoneal cavities of TLR9-/- mice 735 
following Porphymonas gingivalis challenge.  WT and TLR9-/- mice were intraperitoneal 736 
injected with 1x108 CFU of Porphymonas gingivalis and the peritoneal exudate cells 737 
were harvested and stained with anti-TCR-β, anti-B220, anti-CD11b, anti-Ly6G, and 738 
anti-F4/80.  (A) Representative dot plots and the number is representative of the 739 
percentage of cells in that quandrant or gate.  Quantification of the percentage of (B) 740 
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neutrophils and (C) macrophages from the peritoneal lavage exudate from mice 741 
sacrificed at the indicated timepoints.  The averages and standard deviations are 742 
shown.  Five to thirteen mice were analyzed in a minimum of two independent 743 
experiments.   *** P<0.001, **** P<0.0001 744 
 745 
Figure 3.  TLR9-/- gingival tissues exhibit dampened inflammatory responses and 746 
increased expression of negative regulators of inflammation following ligature 747 
placement.  Ligatures were placed in WT and TLR9-/- mice and euthanized 7 days later. 748 
RNA was extracted from gingival tissues and subjected to RT-qPCR (A) Heat map 749 
analysis of mRNA expression profiles of TLRs, TLR signaling pathways, cytokines, 750 
cytokine receptors, and regulators of the TLR pathways by Qiagen PCR Array kit.  As 751 
shown on the color bar, red represents up-regulated genes and green represents down-752 
regulated genes.  (B) Venn diagram showing the unique and overlapping up-regulated 753 
(red) and down-regulated (green) genes in the gingival tissues for each genotype 754 
following ligature-induced inflammation.  Five to six mice were analyzed.  (C) RT-qPCR 755 
analysis of A20 (TNFAIP3) in the gingival tissues of control and ligated WT and TLR9-/- 756 
mice.  Results are reported as fold induction following normalization to GAPDH.  The 757 
averages and standard deviations are shown.   Eight to nine mice were analyzed.  758 
* P<0.05. Abbreviations: Btk, Bruton agammaglobulinemia tyrosine kinase; Ccl2, 759 
Chemokine (C-C motif) ligand 2; IL1β, Interleukin 1 beta; TNF, tumor necrosis factor; 760 
CD80, CD80 antigen; CD86, CD86 antigen; Ly86, Lymphocyte antigen 86; TLR1, Toll-761 
like receptor 1; Cxcl10, Chemokine (C-X-C motif) ligand 10; IL-1R1, Interleukin 1 762 
receptor, type I; TLR9, Toll-like receptor 9; Ptgs2, Prostaglandin-endoperoxide synthase 763 
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2; RipK2, Receptor (TNFRSF)-interacting serine-threonine kinase 2; Peli1, Pellino 1; 764 
Ube2n, Ubiquitin-conjugating enzyme E2N; Ube2v1, Ubiquitin-conjugating enzyme E2 765 
variant 1; Para, Peroxisome proliferator activated receptor alpha; Clec4e, C-type lectin 766 
domain family 4, member e; Ly96, Lymphocyte antigen 96; TLR5, Toll-like receptor 5; 767 
Hmgb1, High mobility group box 1; IL2, Interleukin 2; IFNg, Interferon gamma; Csf2, 768 
Colony stimulating factor 2 (granulocyte-macrophage); IFNb1, Interferon beta 1, 769 
fibroblast; IL-10, Interleukin 10; IL-12a, Interleukin 12A; Map2k3, Mitogen-activated 770 
protein kinase kinase 3; Csf3, Colony stimulating factor 3 (granulocyte); Lta, 771 
Lymphotoxin A;  (A20)Tnfaip3, Tumor necrosis factor, alpha-induced protein 3; IRF1, 772 
Interferon regulatory factor 1; NFkBIL1, Nuclear factor of kappa light polypeptide gene 773 
enhancer in B-cells inhibitor-like 1; NFkB2, Nuclear factor of kappa light polypeptide 774 
gene enhancer in B-cells 2, p49/p100; TLR2, Toll-like receptor 2; TLR7, Toll-like 775 
receptor 7; TLR6, Toll-like receptor 6; TLR8, Toll-like receptor 8; CD14, CD14 antigen. 776 
 777 
Figure 4. Loss of TLR9 in BMDM increased A20 (TNFAIP3) protein induction following 778 
P. gingivalis challenge.  WT and TLR9-/- BMDM were stimulated with heat-killed P. 779 
gingivalis (MOI 1:100) for 2, 4, and 6 hours.  (A) mRNA was isolated and expression of  780 
A20 was determined by RT-qPCR.  Results are reported as fold induction relative to 781 
unstimulated samples following normalization to GAPDH.  Protein lysates were 782 
prepared and (B) representative Western blots and (C) quantification of fold increase in 783 
A20 expression levels relative to unstimulated samples following normalization to the 784 
actin signal.  The average and standard deviation are shown.  Results are 785 
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representative of four mice analyzed in duplicates with a minimum of 2 independent 786 
experiments.  * P<0.05; *** P<0.001. 787 
 788 
Figure 5. Modest increase in A20 (TNFAIP3) mRNA and protein levels in gingival 789 
biopsies from chronic periodontitis patients.  (A) RNA or (B-D) protein was extracted 790 
from gingival biopsies from healthy (H) and chronic periodontitis (CP) patients and 791 
subjected to RT-qPCR and western blotting for A20.  Results are shown as fold 792 
increase relative to healthy patients after normalization to GAPDH (A) or actin (C).   793 
(B) Representative western blot for individual healthy and diseased patients. 794 
Immunohistochemical detection (D) and quantification (E) of A20 in CP patients (n=6) 795 
and H controls (n=5).  Sections were analyzed in sextuplicate in a minimum of 2 796 
independent experiments with averages and standard deviations shown. **p<0.01  797 
       798 
Figure 6.  A representative model of TLR9-mediated periodontal inflammation and 799 
targeted therapeutics.  Periodontal tissues are exposed to various microbe-associated 800 
molecular patterns (MAMPs) and danger-associated molecular patterns (DAMPs) which 801 
are associated with dysbiotic oral microbiome and/or host derived factors. Engagement 802 
of nucleic acids with TLR9 in conjunction with the activation of other innate sensors (e.g. 803 
TLR2 and TLR4) by their respective agonists triggers cytokine/chemokine production 804 
and recruitment of inflammatory cells including neutrophils and macrophages to the site 805 
of infection. Failure to resolve inflammation efficiently and in a timely manner is 806 
detrimental to the host tissues and leads to tissue destruction and tooth loss. Blocking 807 
TLR9 signaling results in reduced neutrophil recruitment at early phases of infection and 808 
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increased A20 expression, an endogeneous regulator of inflammation which may limit 809 
the extent and duration of inflammation at the affected tissues. Targeted therapies to 810 
TLR signaling and downstream molecule A20 potentially provides promising new 811 
therapeutic options to balance the tissue homeostasis and help to resolve deregulated 812 
inflammation preventing adverse clinical outcomes.  813 
 814 
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Table  1:  Clinical Study Population Demographics 
Variable Healthy CP p value 
Gender (n) (males/females) 6/18 26/23 < 0.05 
Age (mean+SD) 43.3+17.7 57.6+12.4 <0.01 
Race (n) 
(white/black/Asian/Hispanic) 
16/6/1/1 28/17/1/3 >0.05 
PD (mm) (mean+SD) 2.38+0.72 4.88+2.31 <0.001 
AL (mm) (mean+SD) 1.02+1.10 5.56+2.88 <0.001 
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